Leading the Future of Botanical Medicines

Leading the Future of Botanical Medicines

Botanicure advances innovative botanical medicines to address unmet medical needs in aging populations, with a focus on dementia and Alzheimer's disease.

Leading the Future of Botanical Medicines
Message from the Chairman

Our Vision & Core Values

According to the World Health Organization, a new case of dementia is diagnosed every three seconds worldwide. As populations age, dementia has become one of the most urgent healthcare challenges of our time.

At Botanicure, we believe botanical medicines offer a unique opportunity to address the complex nature of neurodegenerative diseases through their multi-component and multi-target mechanisms. Leveraging Taiwan's strengths in agricultural science, biotechnology, and advanced analytical technologies, we are committed to developing innovative botanical therapies for unmet medical needs.

Our mission is guided by four core values: Integrity, Altruism, Innovation and Sharing. These principles drive our pursuit of scientific excellence and our commitment to creating meaningful value for patients, families, partners, and society.

Through botanical medicines innovation, we strive to bring new hope to patients living with dementia and contribute to a future where healthy and dignified aging is possible for all.

 

Our Vision:

「Bringing Taiwan's Botanical Medicines Innovation to the World.」 

「Empowering Healthy and Dignified Aging.」

 
Botanicure Co., Ltd.
Yi-Sheng Shyu
Chairman
Message from the Chairman

Board of Directors & Executive Leadership

Strengthening Organizational Excellence with Global Vision
Yi-sheng Shyu
Yi-sheng Shyu
Chairman

Extensive experience in global retail, marketing, and business development. Currently leading the transformation into botanical medicine and life sciences to advance innovation, global expansion, and sustainable growth.

Professional Experience
  • Chairman, Heide Global Trading Co., Ltd.
  • General Manager, Cotton Field Organic
  • Vice President of Sales (Mainland China), Microbio Co., Ltd.
  • General Manager of Procurement, RT-Mart China (Chairman of Northeast China Region)
  • General Manager of Operations, Trust-Mart China
Professional Contributions
  • Frequently invited by the Bureau of Foreign Trade (BOFT), Ministry of Economic Affairs, to share strategic insights on retail market distribution and countermeasures in Mainland China..
  • A facilitator of cross-border and cross-strait industrial exchanges, possessing high-level capabilities in market strategic analysis.
  • Recipient of the Best Manager Award (Mainland China Region) from the world’s top three FMCG corporations (P&G, Unilever, and Nestlé).
Andrew H.-J. Wang 
Andrew H.-J. Wang 
Executive Director

A world-renowned structural biologist and leader in Taiwan's biopharmaceutical R&D. His research on pathogenic protein complexes and drug resistance mechanisms provides critical evidence to advance innovative medicines and anti-infection therapies.

Education
  • 1974 Ph.D. in Chemistry University of Illinois at Urbana-Champaign (UIUC)
  • 1970 M.S. in Chemistry National Taiwan University (NTU)
  • 1967 B.S. in Chemistry National Taiwan University (NTU)
Professional Experience
  • Past President, International Union of Biochemistry and Molecular Biology (IUBMB).
  • Acting Chief Executive Officer, National Biotechnology Research Park.
  • Vice President, Academia Sinica.
  • Director and Distinguished Research Fellow, Institute of Biological Chemistry, Academia Sinica
  • Professor, Department of Cell and Developmental Biology, UIUC.
Areas of Expertise
  • Protein and Nucleic Acid Structure; AI-Driven Structural Drug Development.
  • Systems Biology; Synchrotron Radiation X-ray Crystallography.
  • Antibody and Small Molecule Design.
  • Cell Regenerative Medicine; Botanical New Drug R&D
Honors & Awards
  • Academician, Academia Sinica (2000).
  • Fellow, American Association for the Advancement of Science (AAAS).
  • Fellow, The World Academy of Sciences (TWAS).
  • Distinguished Alumnus, National Taiwan University.
  • Presidential Science Prize (Taiwan).
  • Ranked among the top 2% of scientists globally in the field of DNA (2025).
Zhong-Shyong Shyu
Zhong-Shyong Shyu
Director

A prominent advocate for Taiwan’s disability rights and social welfare, who spearheaded the "Occupational Therapists Act" to significantly advance assistive devices and rehabilitation care.

Education
Ph.D. in Rehabilitation Counseling, University of Northern Colorado (USA)
M.A. in Special Education, University of Northern Colorado (USA).
B.A. in Political Science, Soochow University (Taiwan)
Public Service Experience
  • 2014–2016 Deputy Secretary-General of the Executive Yuan
  • 2010–2014 Vice Mayor of Taichung City
  • 1993–2011 Member of the Legislative Yuan (2nd to 7th Sessions)
Major Awards
Order of Propitious Clouds with Special Grand Cordon (First Class) – Awarded in recognition of his significant national contributions and exceptional service (2016).
Ten Outstanding Young Persons with Disabilities – Golden Perseverance Award (1991).
Political & Public Service Highlights
  • Taiwan’s First Disabled Parliamentarian: Elected to the 2nd Legislative Yuan in 1992, becoming the first-ever elected legislator with a disability in Taiwan.
  • Extensive Legislative Career: Served six consecutive terms in the Legislative Yuan and was a member of the KMT Central Standing Committee.
  • Senior Government Leadership: Served as Deputy Secretary-General of the Executive Yuan, marking one of his most senior roles in the nation's executive branch.
Swee Ho Chng
Swee Ho Chng
Director

A veteran investment consultant with 30+ years of Asia experience, advising sovereign funds, governments, and financial institutions on corporate competitiveness, restructuring, and M&A.

Professional Experience
  • CEO, Botanicure Singapore Subsidiary (Present)
  • Senior Partner and Vice Chairman of Asia Pacific, Oliver Wyman
  • Managing Partner of Greater China and Member of the Global Partnership Council, Kearney
  • Senior Partner and Chairman of China, Head of Asia M&A Practice, Bain & Company
  • Partner and Managing Director of Greater China, Boston Consulting Group (BCG)
  • Independent Director, Beiqi Foton Motor Co., Ltd.
  • Independent Director, Ping An OneConnect Credit Reference (Hong Kong)
  • Non-Executive Chairman of Asia, VenCap International (UK)
Professional Expertise
Superior track record of value and impact creation
Cross-border M&A and Corporate Transformation: Expert in enhancing business competitiveness through restructuring, strategic pivots, and M&A integration.
Major Achievements
Academic Leadership: Served as a Guest Professor at the PBC School of Finance, Tsinghua University, and Xiamen University, and as an MBA Mentor at the Shanghai Advanced Institute of Finance (SAIF).
Global Thought Leadership: Distinguished speaker at prestigious global forums including the World Economic Forum (WEF), Boao Forum for Asia, World Knowledge Forum, Harvard Business School, London Business School, and the LSE.
Dr. MannChing Sherry Ku
Dr. MannChing Sherry Ku
Director

Over 30 years of global experience in transnational drug R&D, biotech operations, and executive management.

Founder and General Manager of Gude Consulting Co., Ltd.

Education
  • Ph.D. in Pharmaceutics and Pharmaceutical Chemistry, The Ohio State University, USA
  • B.S. in Pharmacy, National Taiwan University (NTU)
Key Experience
  • Expert Consultant at the Biomedical Translation Research Center (BTRC), Academia Sinica & Board Member at Centaur Pharmaceuticals.
  • Savior Lifetec Corporation:Former Chairman & CEO; successfully spearheaded the turnaround of the sterile cephalosporin/carbapenem leader into profitability.
  • Rin Hui Biopharm:Former Board Managing Director.
  • Anchen Pharmaceuticals:Former General Manager & Chief Technology Officer (CTO).
  • Wyeth Pharmaceuticals, USA:Former R&D Director, Pharmaceutical Research and Development Department.
Scientific & Industry Contributions
  • Patents & Publications: Holds over 70 international patents and authored more than 62 peer-reviewed scientific papers.
  • Global Authorities: Served as an Expert Committee Member for the United States Pharmacopeia (USP) and President of the Physical Pharmacy and Biopharmaceutics section of the American Association of Pharmaceutical Scientists (AAPS).
Dr. Shinn-Zong Lin
Dr. Shinn-Zong Lin
Director

Superintendent of Hualien Tzu Chi Hospital and Presidential Advisor. A pioneering leader in Taiwan’s stem cell therapy, he is internationally recognized for his clinical R&D in regenerative medicine and neuro-oncology.

Experience
  • Superintendent, Hualien Tzu Chi Hospital
  • Chief R&D Officer, Innovation and Development Center, Buddhist Tzu Chi Medical Foundation
  • Superintendent, Tainan Municipal Annan Hospital
  • Superintendent, Beigang Hospital, China Medical University
  • Chief of Neurosurgery, National Defense Medical Center Triple Service General Hospital
Education & Honors
  • Ph.D. in Neurosurgery and Physiology, State University of New York, USA.
  • M.H.A. (Master of Hospital Administration), Tulane University, USA.
  • M.D., School of Medicine, National Defense Medical Center.
  • Global Academic Fellowships: Elected Fellow of the National Academy of Inventors (NAI), the American Association for the Advancement of Science (AAAS), and the American Institute for Medical and Biological Engineering (AIMBE).
Key Awards
2010 : Received the Outstanding Achievement Award from the American Society for Neural Therapy and Repair (ASNTR)—the first ethnic Chinese scientist to win this prestigious honor.
Fields of Expertise & Research
  • Neurodegenerative Disease Treatment: Specializes in deep brain stimulation (DBS), stem cell therapy, and brain tissue transplantation for Parkinson's disease, dementia, and ALS.
  • Critical Brain Conditions & Surgery: Expert in surgical interventions for malignant brain tumors, cerebral aneurysms, and spinal nerve disorders.
  • Innovative & Regenerative Medicine: Dedicated to stem cell and gene therapy research, while actively promoting the integration of Western and Traditional Chinese Medicine.
Mr. Chung-Hsien Chen
Mr. Chung-Hsien Chen
Director

A senior financial executive in Taiwan and Resident Advisor to Sunny Bank. His leadership background includes serving as Chairman of Mega Futures and General Manager of Mega Investment Trust.

Experience
  • Resident Advisor, Sunny Bank
  • Independent Director, Tien Lik Offshore Wind Technology Co., Ltd.
  • Equity Proprietary Trading Advisor, Mega Securities Co., Ltd.
  • Futures Proprietary Trading Advisor, Mega Futures Co., Ltd.
  • Chairman, Mega Futures Co., Ltd.
  • General Manager, Mega International Investment Trust Co., Ltd.
  • Executive Vice President & General Manager, International Investment Trust Co., Ltd.
Professional Expertise

Financial Markets & Banking Operations: Began his distinguished career at the International Commercial Bank of China (ICBC, now Mega Bank), followed by long-term executive leadership in investment trust and consulting sectors. He possesses profound expertise in global financial markets and foreign banking operations.

To provide you with the best possible service, this website uses cookies. By continuing to browse this site, you agree to our use of cookies. Please refer to our [Privacy Policy] for more information. Please note that if you choose to disable cookies, some features of the site may not function properly.

Manage Cookies

Privacy Preference Center

To provide you with the best possible service, this website uses cookies. By continuing to browse this site, you agree to our use of cookies. Please refer to our [Privacy Policy] for more information. Please note that if you choose to disable cookies, some features of the site may not function properly.

Privacy Policy

Manage consent settings

Necessary Cookies

Enable all by default.

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in, or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.